| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 10/08/2008 | CN100423718C Highly purified ethyl EPA and other EPA derivatives for psychiatric and neurological disorders |
| 10/08/2008 | CN100423717C Pharmaceutical solutions of modafinil compounds and use in preparation of medicine for treatment of diseases |
| 10/08/2008 | CN100423716C Modafinil pharmaceutical compositions |
| 10/08/2008 | CN100423712C Production method of erigeron breviscopus element drop |
| 10/08/2008 | CN100423711C Sodium sulfonate injection of tanshinone óA, and preparation method |
| 10/07/2008 | US7433788 Crystallization of IGF-1 |
| 10/07/2008 | US7432392 Ester derivatives and medical use thereof |
| 10/07/2008 | US7432389 Inhibiting beta-secretase enzyme activity and A beta peptide production, to reduce amyloid beta deposits or plaques |
| 10/07/2008 | US7432374 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 10/07/2008 | US7432364 Polynucleotide which encodes human antibody that binds to tissue inhibitors of metalloproteases; used to diagnose and treat liver & cardiac fibrosis, alcoholic liver disease, acute coronary syndrome, lupus nephritis, glomerulosclerotic renal disease, benign prostate hypertrophy, colon and lung cancer |
| 10/07/2008 | US7432356 Complement pathway inhibitors binding to C5 and C5a without preventing formation of C5b |
| 10/07/2008 | US7432304 Providing cell which overexpresses a Bcl-2 family protein; gossypol compound; treating with cell with an effective amount of gossypol compound under conditions such that apoptosis in cell is modulated |
| 10/07/2008 | US7432299 Use of alpha-2-delta ligands such as gabapentin, pregabalin and other alpha-2-delta ligands such as [6-(Aminomethyl)bicyclo[3.2.0]hept-6-yl]acetic acid; treatment of premature ejaculation |
| 10/07/2008 | US7432296 Pharmaceutical formulations containing substituted 2-aryl-aminoacetic acid compounds and/or substituted 2-heteroaryl-aminoacetic acid compounds |
| 10/07/2008 | US7432290 Claimed is 1-Cyanobutan-2-yl-1-[3-[3-[3-methoxy-4-(oxazol-5-yl)phenyl]ureido]phenyl] ethylcarbamate, AVN 944, VX-944 |
| 10/07/2008 | US7432289 5-Acylamino-1,1′-biphenyl-4-carboxamide derivatives and their use as P38 kinase inhibitors |
| 10/07/2008 | US7432286 Pharmaceutically active sulfonyl hydrazide derivatives |
| 10/07/2008 | US7432285 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use |
| 10/07/2008 | US7432270 N-aroyl cyclic amines |
| 10/07/2008 | US7432263 Amino-phthalazinone derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them |
| 10/07/2008 | US7432244 Administering peptides useful in treating disorders caused or mediated by insulin-like growth factors, such as cancer, diabetic complications, acromegaly, age-related macular degeneration, ischemic injuries, or traumas |
| 10/07/2008 | US7432243 A nucleic acid molecule that encodes at least one polypeptide useful as antiangiogenic, tumor suppressive and antimigratory agent |
| 10/07/2008 | US7432240 Fumaric acid amides |
| 10/07/2008 | US7432060 Using gene expression pattern of cardiac specific transcription factors to diagnose and treat cardiac hypertrophy, myocardial infarction, stroke, arteriosclerosis and heart failure |
| 10/07/2008 | US7431943 Controlled release and taste masking oral pharmaceutical compositions |
| 10/07/2008 | US7431925 Internal image antibodies for optical imaging and therapy |
| 10/07/2008 | CA2482124C Methods of treatment using an epithelial sodium channel blocker and an inhibitor of the mineralocorticoid receptor |
| 10/07/2008 | CA2435946C Piperidine derivatives as neurokinin 1 antagonists |
| 10/07/2008 | CA2433772C Pyrimidine matrix metalloproteinase inhibitors |
| 10/07/2008 | CA2427573C Indole derivatives as pde5-inhibitors |
| 10/07/2008 | CA2426009C Cholesterol lowering benzo[b]thiophenes and benzo[d]isothiazoles |
| 10/07/2008 | CA2416685C Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids |
| 10/07/2008 | CA2411544C N-alkyl-adamantyl triazinyl benzamide derivatives |
| 10/07/2008 | CA2362582C Use of 15-deoxyspergualin for the treatment of hyperreactive inflammatory diseases and autoimmune diseases |
| 10/07/2008 | CA2359872C Gels formed by the interaction of poly(aldehyde) with various substances |
| 10/07/2008 | CA2331461C Analogs of 2-phthalimidinoglutaric acid and their use as inhibitors of angiogenesis |
| 10/07/2008 | CA2225022C New polymorphous form of doxazosine mesylate (form iii) |
| 10/07/2008 | CA2181909C Aromatic 2-amino-imidazole derivatives as alpha-2a adrenoceptor agonists |
| 10/02/2008 | WO2008118862A1 Carotenoid analogs and derivatives for the prevention of platelet aggregation |
| 10/02/2008 | WO2008118711A2 Method of inhibiting complement activation with human anti-factor c3 antibodies and use thereof |
| 10/02/2008 | WO2008118552A1 Use of ranolazine for the treatment of cardiovascular diseases |
| 10/02/2008 | WO2008118454A2 Derivatives of quinoline or benzopyrazine and their uses for the treatment of (inter alia) inflammatory diseases, autoimmune diseases or various kinds of cancer |
| 10/02/2008 | WO2008118320A1 Reduction of adverse events.after percutaneous intervention by use of a thrombin receptor antagonist |
| 10/02/2008 | WO2008117862A1 Novel (2-aminophenyl)pyridinecarboxamide derivative having urea structure |
| 10/02/2008 | WO2008117815A1 Inhibitor for cell death caused by endoplasmic reticulum stress or oxidation stress |
| 10/02/2008 | WO2008117707A1 Ground crystal of olmesartan medoxomil |
| 10/02/2008 | WO2008117303A1 Indole derivatives and their metal conjugates and uses thereof |
| 10/02/2008 | WO2008116926A1 Tetrahydroindole derivatives as nadph oxidase inhibitors |
| 10/02/2008 | WO2008116914A1 Purinyl derivatives and their use as potassium channel modulators |
| 10/02/2008 | WO2008116911A1 Purinyl derivatives and their use as potassium channel modulators |
| 10/02/2008 | WO2008116910A1 Purinyl derivatives and their use as potassium channel modulators |
| 10/02/2008 | WO2008116909A1 Purinyl derivatives and their use as potassium channel modulators |
| 10/02/2008 | WO2008116898A1 Pyrazolo [1,5-a]pyrimidines as inhibitors of stearoyl-coa desaturase |
| 10/02/2008 | WO2008099091A3 Use of ivabradine for obtaining drugs for treating endothelial dysfunction |
| 10/02/2008 | WO2008099025A3 Body-weight maintenance and body composition |
| 10/02/2008 | WO2008073958A3 Substituted benzothiadiazinedioxide derivatives and methods of their use |
| 10/02/2008 | WO2008050161A3 Peptides for activation of angiogenesis, pharmaceutical compounds containing same and use of these compounds |
| 10/02/2008 | WO2008020260A3 Use of siderophores in prevention of vascular diseases, production of siderophores and qualifying siderophore containing meat-products |
| 10/02/2008 | US20080242840 Saposin B specific monoclonal antibody for use in treatment and prevention of cell proliferative disorders |
| 10/02/2008 | US20080242732 Administering pharmaceutical orally at dose-delivery rate sufficient to provide clinically effective blood level in portal vein, less than required for blood level in peripheral circulation to provide dose-delivery selective in liver |
| 10/02/2008 | US20080242725 pharmaceutical ingredients susceptible to conversion to alternate polymorph forms are prepared by a process of wet granulation in which the ratios of active, fillers, and granulating liquid are controlled in order to avoid polymorphic interconversions |
| 10/02/2008 | US20080242716 Ion Channel Modulators |
| 10/02/2008 | US20080242712 Identification and uses of novel PPAR ligands that do not cause fluid retention, edema or congestive heart failure |
| 10/02/2008 | US20080242711 Inhibitors of cholesterol ester transfer protein |
| 10/02/2008 | US20080242700 Methods and Compositions for Selectin Inhibition |
| 10/02/2008 | US20080242687 endothelin modulators/antagonists; reduced hepatoxicity; hypotensive agents; Deuterated Pyrimidine Derivatives like 4-tert-Butyl-N-[6-(2-hydroxy-ethoxy)-5-(2-methoxy-phenoxy)-[2,2']bipyrimidinyl-4-yl]-benzenesulfonamide |
| 10/02/2008 | US20080242681 N-4-(6-(Hetero)Aryl-Pyrimidin-4-Ylaminophenyl)-Benzenesulfonamides as Kinase Inhibitors |
| 10/02/2008 | US20080242668 Neurodegenerative, inflammatory disorders, pain, drug abuse; useful as diagnostic tools or monitoring agents such as for neuroimaging, labelling; nicotinic and/or monoamine receptors modulators; 2,2'-Bis-((+-)-1-aza-bicyclo[2.2.2]oct-3-yloxy)-[5,5']-bithiazolyl; cholinergic ligands |
| 10/02/2008 | US20080242660 1,4-diazepin-1-sulfonyl-isoquinoline derivatives; Rho kinase, myosin light chain kinase or protein kinase C inhibitor; relaxing effect on vascular smooth muscles; hypotensive and vasodilating agent; occlusion or stenosis of an artery |
| 10/02/2008 | US20080242659 Compositions and methods for reducing cardiovascular morbidity and/or mortality |
| 10/02/2008 | US20080242654 Novel compounds as cannabinoid receptor ligands |
| 10/02/2008 | US20080242652 Indole derivatives and their metal conjugates and uses thereof |
| 10/02/2008 | US20080242639 Phosphagen Synthesis |
| 10/02/2008 | US20080242632 Targets two or more Dna sequence ; anticancer agents, therapy for infections, antiinflammatory agents, autoimmune diseases; respiratory system disorders; liver disorders |
| 10/02/2008 | US20080242629 Hybrid nucleic acids; controlling gene expression; metabolism disorders, obesity, diabetes |
| 10/02/2008 | US20080242619 Peptidomimetics ; determine ability to bind to growth hormone secretagogue; ghrelin antagonist; appetite stimulation; dietetics ; weight maintenance; eating disorders |
| 10/02/2008 | US20080242615 Surfactant protein-d for prevention and treatment of lung infections and sepsis |
| 10/02/2008 | US20080242613 Protease activated receptors; angiogenesis inhibitor; cardiovascular disorders |
| 10/02/2008 | US20080242591 Treating vascular malformation with nicotinic acetylcholine receptor (nAChR) antagonist; arthritis, cancer |
| 10/02/2008 | US20080242587 Including nucleotide sequence encoding Tie2 and vascular endothelial growth factor receptor (VEGF) components; edema and tumor growth prevention |
| 10/02/2008 | US20080241961 Drosophila g protein coupled receptors, nucleic acids, and mehtods related to the same |
| 10/02/2008 | US20080241960 Insulin-like growth factor binding protein specific monoclonal antibody for use in diagnosis, prevention and treatment of cell proliferative, inflammatory, autoimmune, muscular and vision disorders |
| 10/02/2008 | US20080241923 Using cc-chemokine receptor 2 (CCR2) specific immunoglobulin for treatment and prevention of viral infection, inflammatory, autoimmune, graft rejection and cardivascular disorders |
| 10/02/2008 | US20080241905 Retroviral vector comprising nucleotide sequences coding collagen domain for use in wound healing; tissue repair and engineering; regenerative medicine |
| 10/02/2008 | US20080241835 Differentially expressed genes involved in angiogenesis, the polypeptides encoded thereby, and methods of using the same |
| 10/02/2008 | US20080241279 Materials and methods of using calcium for reduction of inflammation |
| 10/02/2008 | US20080241261 Tablets utillizing polyvinylpyrrolidone finely dispersed in polyvinyl acetate; high dosage levels; applicable to drugs, nutraceuticals, vitamins, minerals, trace elements |
| 10/02/2008 | US20080241240 Dihydropyridine derivative delayed and statin rapid release components; preventing antagonistic and other adverse side effects; atherosclerosis, hypertension; dosage kits |
| 10/02/2008 | US20080241239 Pharmaceutical Tablets Having a Separation Mark Positioned on the Side of Said Tablets |
| 10/02/2008 | US20080241218 Intravascular stent having an iridium oxide, gold, platinum, titanium or inert carbon coating, and a number or reservoirs with an antibiotic, anticoagulant, antiproliferative, bactericide, angiogenesis inhibitor, growth factor, or radionuclide; greater control of drug placement and coating durability |
| 10/02/2008 | US20080241208 Methods, Compositions and Devices For Promoting Anglogenesis |
| 10/02/2008 | US20080241198 Selective angiogenesis and gene expression inhibition of the vascular endothelial growth factor pathway; ocular disease; antiarthritic, antiinflammatory agents |
| 10/02/2008 | US20080241165 Controlling extracellular protein degradation and/or clearance via modulation of tissue plasminogen activator activity; treating diabetic, autoimmune, cardiovascular, blood and nervous system disorders |
| 10/02/2008 | US20080241159 Methods and compositions for selective modulation of vascularization |
| 10/02/2008 | US20080241158 G-protein coupled receptors for use in identifying modulators for treatment and prevention of cell proliferative, neurological, cardiovascular, gastrointestinal, autoimmune/inflammatory, metabolic and viral disorders |
| 10/02/2008 | US20080241153 Vascular Endothelial Growth Factor C (VEGF-C) Protein and Gene, Mutants Thereof, and Uses Thereof |
| 10/02/2008 | US20080241152 Vascular Endothelial Growth Factor C (VEGF-C) Protein and Gene, Mutants Thereof, and Uses Thereof |
| 10/02/2008 | US20080241136 Using cc-chemokine receptor 2 (CCR2) specific immunoglobulins for use in treatment and prevention of skin disorders |
| 10/02/2008 | US20080241134 Uses of human monoclonal antibodies against oxidized ldl receptor |
| 10/02/2008 | US20080241131 Using sphingosine kinase-2 as tool in identifying modulators for use in treatment of cell proliferative disorders |